Suven Life Sciences Limited (BOM:530239)
India
· Delayed Price · Currency is INR 289.35
+13.75 (4.99%)
At close: Jul 14, 2025
Suven Life Sciences Revenue
In the fiscal year ending March 31, 2025, Suven Life Sciences had annual revenue of 66.56M INR, down -43.08%. Suven Life Sciences had revenue of 14.67M in the quarter ending March 31, 2025, a decrease of -38.50%.
Revenue
66.56M
Revenue Growth
-43.08%
P/S Ratio
974.74
Revenue / Employee
472.04K
Employees
141
Market Cap
64.88B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 66.56M | -50.37M | -43.08% |
| Mar 31, 2024 | 116.93M | -19.02M | -13.99% |
| Mar 31, 2023 | 135.95M | 16.44M | 13.76% |
| Mar 31, 2022 | 119.51M | -21.23M | -15.08% |
| Mar 31, 2021 | 140.73M | -6.32M | -4.30% |
| Mar 31, 2020 | Pro | Pro | Pro |
| Mar 31, 2019 | Pro | Pro | Pro |
| Mar 31, 2018 | Pro | Pro | Pro |
| Mar 31, 2017 | Pro | Pro | Pro |
| Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Reliance Industries | 9,646.93B |
| HDFC Bank | 2,728.47B |
| Tata Consultancy Services | 2,561.48B |
| Bharti Airtel | 1,729.85B |
| ICICI Bank | 2,006.54B |
| State Bank of India | 3,429.39B |
| Infosys | 1,647.16B |
| Hindustan Unilever | 631.21B |
Suven Life Sciences News
- 6 months ago - Suven Life Sciences shares surge over 8% after clinical trial update - Business Upturn
- 6 months ago - Suven Life Sciences initiates Phase-1 clinical trial for SUVN-I6107 - Business Upturn
- 10 months ago - Suven Life Sciences reports positive Phase-2a results for Ropanicant in treating Major Depressive Disorder - Business Upturn
- 11 months ago - Suven Life Sciences announces FDA acceptance of Investigational New Drug - Business Upturn